Literature DB >> 19036902

Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary.

Shunichi Matsumoto1, Koshi Hashimoto, Masanobu Yamada, Teturou Satoh, Junko Hirato, Masatomo Mori.   

Abstract

The liver X receptors (LXR-alpha and -beta) are nuclear oxysterol receptors that play pivotal roles in regulating the expression of genes involved in cholesterol transport and metabolism. Recently, several groups have reported that the LXRs also regulate adrenal steroidogenesis. However, the roles of LXRs in the hypothalami-pituitary-adrenal axis, especially whether they regulate proopiomelanocortin (POMC) gene expression in the pituitary, remain to be elucidated. In this report, we demonstrate that LXR mRNA is expressed in the pituitary and that at the protein level, LXR-alpha is dominantly expressed. Next, we show that the LXR agonist TO901317 (TO) increased POMC mRNA levels and the number of cells immunostained with anti-ACTH antibody in the mouse pituitary. We also confirmed that TO elevated plasma ACTH and serum corticosterone levels in vivo and increased the total tissue content of immunoreactive ACTH in the pituitary. TO activated the rat POMC gene promoter (-706/+64 bp) in GH3 and AtT-20 cells. Silencing of LXR-alpha mRNA expression in GH3 cells with small interfering RNA specific to LXR-alpha caused a loss of promoter activity induced by the LXR ligand, suggesting that LXR-alpha directly regulates the POMC gene promoter. EMSAs also demonstrated that the retinoid X receptor-alpha/LXR-alpha heterodimer bound to the region between -73 and -52 bp in the rat POMC gene promoter, and this site was responsible for the induction by TO, as confirmed by chromatin immunoprecipitation assays using AtT-20 cells. Our findings provide the first evidence that LXR-alpha positively regulates the POMC gene promoter at the transcriptional level and suggest LXR-alpha to be a coordinator for cross talk between lipid metabolism and neuroendocrinology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036902      PMCID: PMC5419326          DOI: 10.1210/me.2007-0533

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  38 in total

Review 1.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 2.  Oxysterols: modulators of cholesterol metabolism and other processes.

Authors:  G J Schroepfer
Journal:  Physiol Rev       Date:  2000-01       Impact factor: 37.312

3.  Mouse cytochrome P450 (Cyp3a11): predominant expression in liver and capacity to activate aflatoxin B1.

Authors:  T Yanagimoto; S Itoh; M Sawada; T Kamataki
Journal:  Arch Biochem Biophys       Date:  1997-04-15       Impact factor: 4.013

4.  A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.

Authors:  R Apfel; D Benbrook; E Lernhardt; M A Ortiz; G Salbert; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

5.  Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP).

Authors:  Koshi Hashimoto; Masanobu Yamada; Tsuyoshi Monden; Teturou Satoh; Fredric E Wondisford; Masatomo Mori
Journal:  Mol Cell Endocrinol       Date:  2005-01-14       Impact factor: 4.102

Review 6.  The role of orphan nuclear receptors in the regulation of cholesterol homeostasis.

Authors:  J J Repa; D J Mangelsdorf
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

7.  Glucocorticoids regulate hippocampal 11 beta-hydroxysteroid dehydrogenase activity and gene expression in vivo in the rat.

Authors:  S C Low; M P Moisan; J M Noble; C R Edwards; J R Seckl
Journal:  J Neuroendocrinol       Date:  1994-06       Impact factor: 3.627

8.  Liver X receptor-alpha gene expression is positively regulated by thyroid hormone.

Authors:  Koshi Hashimoto; Shunichi Matsumoto; Masanobu Yamada; Teturou Satoh; Masatomo Mori
Journal:  Endocrinology       Date:  2007-07-12       Impact factor: 4.736

9.  T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.

Authors:  Nico Mitro; Leo Vargas; Russell Romeo; Alan Koder; Enrique Saez
Journal:  FEBS Lett       Date:  2007-03-30       Impact factor: 4.124

10.  The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse.

Authors:  Jeffrey W Chisholm; Jenny Hong; Scott A Mills; Richard M Lawn
Journal:  J Lipid Res       Date:  2003-08-16       Impact factor: 5.922

View more
  12 in total

1.  Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.

Authors:  Jie Lu; Grégoire P Chatain; Alejandro Bugarini; Xiang Wang; Dragan Maric; Stuart Walbridge; Zhengping Zhuang; Prashant Chittiboina
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

2.  Group X secretory phospholipase A2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands.

Authors:  Preetha Shridas; William M Bailey; Boris B Boyanovsky; Rob C Oslund; Michael H Gelb; Nancy R Webb
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

3.  Site-directed mutagenesis of human cytosolic sulfotransferase (SULT) 2B1b to phospho-mimetic Ser348Asp results in an isoform with increased catalytic activity.

Authors:  Emily D Salman; Dongning He; Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  J Steroid Biochem Mol Biol       Date:  2011-08-06       Impact factor: 4.292

Review 4.  The human POMC gene promoter: where do we stand?

Authors:  F Pecori Giraldi; F Cassarino; L Pagliardini; V Asnaghi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 5.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

Review 6.  Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolism.

Authors:  Jinhan He; Qiuqiong Cheng; Wen Xie
Journal:  Mol Endocrinol       Date:  2009-09-17

Review 7.  Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.

Authors:  Deborah A Finn; Ethan H Beckley; Katherine R Kaufman; Matthew M Ford
Journal:  Horm Behav       Date:  2009-07-15       Impact factor: 3.587

8.  Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway.

Authors:  Kumsun Cho; Jae Yong Chung; Sung Kweon Cho; Hyun-Woo Shin; In-Jin Jang; Jong-Wan Park; Kyung-Sang Yu; Joo-Youn Cho
Journal:  Sci Rep       Date:  2015-01-30       Impact factor: 4.379

9.  Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease.

Authors:  Dongyun Zhang; Robert Damoiseaux; Lilit Babayan; Everett Kanediel Rivera-Meza; Yingying Yang; Marvin Bergsneider; Marilene B Wang; William H Yong; Kathleen Kelly; Anthony P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

10.  Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform.

Authors:  Jaime Freitas; Nicole Miller; Brenda J Mengeling; Menghang Xia; Ruili Huang; Keith Houck; Ivonne M C M Rietjens; J David Furlow; Albertinka J Murk
Journal:  Curr Chem Genom Transl Med       Date:  2014-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.